Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
8,92 USD | -0,11% | -15,61% | +12,06% |
Omzet 2024 * | - | Omzet 2025 * | - | Marktkapitalisatie | 991 mln. 927 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -195 mln. -182 mln. | Nettowinst (verlies) 2025 * | -209 mln. -195 mln. | EV/omzet 2024 * | - |
Nettoliquiditeiten 2024 * | 92,93 mln. 86,92 mln. | Nettoliquiditeiten 2025 * | 93,52 mln. 87,47 mln. | EV/omzet 2025 * | - |
K/w-verhouding 2024 * |
-4,9
x | K/w-verhouding 2025 * |
-5,15
x | Werknemers | 76 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 88,4% |
Recentste transcriptie over Centessa Pharmaceuticals plc
1 dag | -0,11% | ||
1 week | -15,61% | ||
Lopende maand | -21,06% | ||
1 maand | -17,10% | ||
3 maanden | +9,99% | ||
6 maanden | +31,37% | ||
Lopend jaar | +12,06% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Saurabh Saha
CEO | Chief Executive Officer | 47 | 01-01-21 |
Director of Finance/CFO | 53 | 01-03-21 | |
Ellie Im
CTO | Chief Tech/Sci/R&D Officer | - | 03-10-23 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 61 | 23-02-21 | |
Chairman | 54 | 01-11-20 | |
Brett Zbar
BRD | Director/Board Member | 51 | 01-01-21 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.02% | 0 M€ | 0,00% | - | |
0.01% | 0 M€ | 0,00% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
26-04-24 | 8,92 | -0,11% | 254 924 |
25-04-24 | 8,93 | -5,60% | 286 596 |
24-04-24 | 9,46 | +0,64% | 2 251 501 |
23-04-24 | 9,4 | -6,00% | 200 077 |
22-04-24 | 10 | -5,39% | 210 810 |
uitgestelde koers Nasdaq, 26 april 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+12,06% | 991 mln. | |
+1,51% | 42,75 mld. | |
+49,22% | 41,61 mld. | |
+8,57% | 41,34 mld. | |
-12,36% | 26,59 mld. | |
+8,92% | 25,49 mld. | |
-25,13% | 18,12 mld. | |
+29,17% | 12,24 mld. | |
-3,12% | 11,76 mld. | |
+6,35% | 11 mld. |